Hyperglycemia also augments insulin and insulin-like growth factor (IGF-1) signaling, activating the PI3K/AKT/mTOR pathway, which enhances cellular proliferation, survival, and angiogenesis while suppressing antitumor immune surveillance (29, 30). The gene discussed is IGF1; the disease is Hyperglycemia.